Your browser doesn't support javascript.
loading
Glucagon-receptor-antagonism-mediated ß-cell regeneration as an effective anti-diabetic therapy.
Xi, Yannan; Song, Benbo; Ngan, Iris; Solloway, Mark J; Humphrey, Mark; Wang, Yan; Mondal, Kalyani; Wu, Hao; Liu, Wenhui; Lindhout, Darrin A; Li, Diana; Matern, Hugo; Kekatpure, Avantika; Haldankar, Raj; Kaplan, Daniel D; Yang, Hong; Pedersen, Ophelia; Chen, Anna; Zhou, Mei; Winans, Bethany; Guo, Wei; Kutach, Alan; Fanget, Marie; Fox, Michael; Tang, Jie; Zha, Jiping; Younis, Husam; Shen, David; DePaoli, Alex; Tian, Hui; Liu, Zhonghao.
Afiliación
  • Xi Y; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Song B; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Ngan I; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Solloway MJ; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Humphrey M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Wang Y; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Mondal K; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Wu H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Liu W; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Lindhout DA; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Li D; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Matern H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Kekatpure A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Haldankar R; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Kaplan DD; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Yang H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Pedersen O; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Chen A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Zhou M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Winans B; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Guo W; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Kutach A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Fanget M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Fox M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Tang J; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Zha J; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Younis H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Shen D; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • DePaoli A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Tian H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA.
  • Liu Z; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA. Electronic address: zhliu74@gmail.com.
Cell Rep ; 39(9): 110872, 2022 05 31.
Article en En | MEDLINE | ID: mdl-35649369
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Células Secretoras de Glucagón / Células Secretoras de Insulina / Hiperglucemia Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Células Secretoras de Glucagón / Células Secretoras de Insulina / Hiperglucemia Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos